NCT06146608

Brief Summary

The FeMicrobiome study will evaluate gut microbiome features and their relationships with dietary iron absorption in healthy adults. The investigators hypothesize that (1) the gut microbiota can be shaped by the heme and non-heme Fe content of the diet and that (2) this will influence individual variation in dietary Fe absorption.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 11, 2023

Completed
5 months until next milestone

First Posted

Study publicly available on registry

November 24, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 14, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 14, 2026

Completed
Last Updated

February 24, 2025

Status Verified

February 1, 2025

Enrollment Period

3 years

First QC Date

July 11, 2023

Last Update Submit

February 21, 2025

Conditions

Outcome Measures

Primary Outcomes (8)

  • The percent of non-heme iron absorption

    Percent non-heme iron absorption will be determined by red blood cell iron incorporation of stable 57Fe

    2-week

  • The concentrations of hemoglobin

    The concentrations of hemoglobin (d/dL)

    baseline

  • The concentrations of ferritin

    The concentrations of ferritin (ug/L)

    baseline

  • Serum transferrin receptor

    Serum transferrin receptor in mg/L

    baseline

  • The hematocrit

    Blood hematocrit in %

    baseline

  • Habitual dietary information

    Habitual dietary information will be obtained from Diet History Questionnaire III.

    baseline

  • Dietary information on the day prior to iron dosing

    Detailed dietary information about all foods and beverages consumed on the day prior to iron dosing will be obtained from the Automated Self-Administered 24-Hour Dietary Assessment Tool. Total iron intake will be presented as a proportion of the daily iron requirement. Total heme and non-heme iron intakes will be quantified.

    baseline

  • Gut microbiome composition

    Shotgun metagenomic sequencing will be performed to assess the gut microbiome compositions and gene functional features in a stool sample collected within one day before or after iron dosing.

    baseline

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

120 healthy adults who habitually consume plant-based diets or habitually consume diets containing animal protein

You may qualify if:

  • Healthy adults
  • Age between 18- 40y
  • Non-smoking
  • Not currently taking vitamin, mineral, prebiotic, and probiotic supplements.
  • Females: premenopausal and not pregnant or lactating
  • No preexisting medical complications (such as eating disorders, hemoglobinopathies, malabsorption diseases, steroid use, substance abuse history, or taking medications known to influence iron homeostasis)
  • Body mass index (BMI) between 18 - 27 kg/m2.

You may not qualify if:

  • BMI \<18 or \> 27 kg/m2,
  • Age \<18 y or \> 40y,
  • Smoking
  • Pregnancy, lactating
  • Have gastrointestinal disorders/malabsorption diseases/hemoglobinopathies/dietary restrictions/steroid use/ medication use of medications known to impact iron status, iron utilization or inflammatory status
  • Currently take vitamin, mineral, prebiotic, and probiotic supplements.
  • Recently received antibiotic treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cornell University

Ithaca, New York, 14853, United States

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Plasma samples and fecal DNA

MeSH Terms

Conditions

Anemia, Iron-DeficiencyIron Overload

Condition Hierarchy (Ancestors)

Anemia, HypochromicAnemiaHematologic DiseasesHemic and Lymphatic DiseasesIron DeficienciesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • KIMBERLY ORA OBRIEN, PhD

    Cornell University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kimberly O O'Brien, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2023

First Posted

November 24, 2023

Study Start

January 15, 2023

Primary Completion

January 14, 2026

Study Completion

January 14, 2026

Last Updated

February 24, 2025

Record last verified: 2025-02

Locations